Evidence map›Paper›PMID 40354339›Full record

ArticlePLoS neglected tropical diseases2025

XDR typhoid in Pakistan: A threat to global health security and a wake-up call for antimicrobial stewardship.

Muhammad Ahmed Abdullah, Babar Tasneem Shaikh, Maryam Ashraf, Shahzad Ali Khan

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Muhammad Ahmed AbdullahSchool of Public Health, Health Services Academy, Islamabad, Pakistan.
Babar Tasneem ShaikhSchool of Public Health, Health Services Academy, Islamabad, Pakistan.ORCID 0000-0002-2056-4132
Maryam AshrafSchool of Public Health, Health Services Academy, Islamabad, Pakistan.
Shahzad Ali KhanSchool of Public Health, Health Services Academy, Islamabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensively drug-resistant (XDR) typhoid, caused by Salmonella enterica serotype Typhi, has emerged as a critical global health security threat, with Pakistan, particularly Sindh province, at its epicenter. The misuse of antibiotics, inadequate diagnostic tools, and poor water and sanitation infrastructure have created ideal conditions for the rise of antimicrobial resistance (AMR). XDR typhoid strains resistant to multiple first-line antibiotics have been linked to environmental contamination, with urban areas like Karachi demonstrating high rates of waterborne transmission. International travel has amplified this threat, exporting cases to countries including the United States, the United Kingdom, and Canada, thus highlighting its global implications. This commentary examines the historical context of typhoid treatment, the drivers of AMR in Pakistan, and the critical role of antimicrobial stewardship in combating XDR typhoid. It advocates for an integrated approach that would encompass improvements in water quality, expanded vaccination coverage with typhoid conjugate vaccines (TCVs), and stringent audit of antibiotic prescription practices. Immediate local and global action is needed to contain this public health crisis and prevent the resurgence of typhoid as a largely untreatable disease. This situation underscores the urgency of addressing AMR to safeguard global health security.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipDrug Resistance, Multiple, BacterialSalmonella typhiTyphoid FeverGlobal HealthHumansPakistanTyphoid-Paratyphoid VaccinesAnti-Bacterial AgentsTyphoid-Paratyphoid Vaccines

Identifiers

PMID40354339
PMCPMC12068562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.